Blepharitis Drugs Market

Global Blepharitis Drugs Market Size, Share & Trends Analysis Report, By Type (Steroids, Antibiotics), By Therapy (Monotherapy, Combination Drug Therapy) Forecast (2021-2027)
    Update Available - Forecast 2024-2030   

Published: Jul 2023 | Report Code: OMR2025254 | Category : Pharmaceuticals | Delivery Format: /

The global blepharitis drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). This eye disease leads to inflammation of the eyelids that can cause them to become swollen, irritated, and red. There are generally 2 major categories of blepharitis that include anterior blepharitis and posterior blepharitis. The major factor attributable to the growth of blepharitis drugs includes the rising prevalence of ophthalmological disorders, such as uveitis, and dry eye, among others. The rise in the geriatric patients’ population, coupled with the awareness about minor eye disorders are the other pivotal factors affecting the growth of the global blepharitis drugs market. 

Furthermore, surging demand for advanced treatment, rising awareness among mass regarding eye care, and government initiatives, among others, are also the driving factors supporting the market growth. Adding to this, there are high unmet medical needs related to eye care which are further anticipated to augment the global market growth. The major causes of the same include inadequate eye hygiene habits, an increasing number of post-operative eye infections, coupled with the emergence of new pathogens. For instance, as per the survey conducted by the National Ambulatory Medical Care Survey, alone in the year 2005, over 4.0 million Americans made visits to ambulatory physicians for bacterial conjunctivitis. Thus, similar rising cases of blepharitis are anticipated to surge its drugs market growth.

Some key players operating in the market include Akorn Inc., Allergan Plc, Bausch Health Companies, Inc., Novartis AG, and Pfizer Inc. These players are eyeing on strengthening their position in the market by adopting various strategies as mergers and acquisitions, partnerships, collaborations, new product launch and development in the existing product portfolio, and so on.

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segment Covered
  • Regions Covered- Globally

Competitive Landscape:  Akorn Inc., Allergan Plc, Bausch Health Companies, Inc., Novartis AG, and Pfizer Inc.

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominates the market in base year?
  • Which segment and region will project fastest growth in the market?
  • How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Blepharitis Drugs Market - Segmentation

By Application 

Steroids

Antibiotics

By Therapy

Monotherapy

Combination Drug Therapy

Global Blepharitis Drugs Market Segmentation by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

Rest of the World